ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,395 | -52.1% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | -20.0% | 100 | -32.4% | 0.00% | – |
| Q3 2019 | $5,000 | – | 148 | +1750.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 8 | -94.6% | 0.00% | – |
| Q4 2016 | $5,000 | -44.4% | 149 | -52.2% | 0.00% | – |
| Q3 2013 | $9,000 | +50.0% | 312 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |